1. Home
  2. CHRO vs MOVE Comparison

CHRO vs MOVE Comparison

Compare CHRO & MOVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHRO
  • MOVE
  • Stock Information
  • Founded
  • CHRO 2002
  • MOVE 2018
  • Country
  • CHRO United States
  • MOVE United States
  • Employees
  • CHRO N/A
  • MOVE N/A
  • Industry
  • CHRO
  • MOVE Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • CHRO
  • MOVE Health Care
  • Exchange
  • CHRO Nasdaq
  • MOVE Nasdaq
  • Market Cap
  • CHRO 8.4M
  • MOVE 7.3M
  • IPO Year
  • CHRO 2024
  • MOVE 2021
  • Fundamental
  • Price
  • CHRO $0.95
  • MOVE $1.00
  • Analyst Decision
  • CHRO Strong Buy
  • MOVE Buy
  • Analyst Count
  • CHRO 1
  • MOVE 1
  • Target Price
  • CHRO N/A
  • MOVE $30.00
  • AVG Volume (30 Days)
  • CHRO 2.1M
  • MOVE 44.9K
  • Earning Date
  • CHRO 05-13-2025
  • MOVE 05-23-2025
  • Dividend Yield
  • CHRO N/A
  • MOVE N/A
  • EPS Growth
  • CHRO N/A
  • MOVE N/A
  • EPS
  • CHRO N/A
  • MOVE N/A
  • Revenue
  • CHRO N/A
  • MOVE $1,013,000.00
  • Revenue This Year
  • CHRO N/A
  • MOVE $1,460.71
  • Revenue Next Year
  • CHRO N/A
  • MOVE N/A
  • P/E Ratio
  • CHRO N/A
  • MOVE N/A
  • Revenue Growth
  • CHRO N/A
  • MOVE N/A
  • 52 Week Low
  • CHRO $0.45
  • MOVE $0.71
  • 52 Week High
  • CHRO $3.80
  • MOVE $8.85
  • Technical
  • Relative Strength Index (RSI)
  • CHRO 35.68
  • MOVE 44.96
  • Support Level
  • CHRO $0.91
  • MOVE $0.75
  • Resistance Level
  • CHRO $1.14
  • MOVE $1.34
  • Average True Range (ATR)
  • CHRO 0.12
  • MOVE 0.13
  • MACD
  • CHRO -0.01
  • MOVE 0.09
  • Stochastic Oscillator
  • CHRO 17.04
  • MOVE 43.88

About CHRO Chromocell Therapeutics Corporation

Channel Therapeutics Corp is a clinical-stage biotechnology company developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain. The initial clinical focus is to selectively target the sodium ion channel known as NaV1.7 for the treatment of various types of chronic, visceral pain, acute and chronic eye pain, and post-surgical nerve blocks. Its pipeline includes CC8464 for ISFN and EM and CT2000 for Acute and CHronic Eye Pain-Dry Eye Disease.

About MOVE Movano Inc.

Movano Inc is developing a platform to deliver purpose-driven healthcare solutions to bring medical-grade, high-quality data to the forefront of consumer health devices. its initial commercial product in development is the Evie Ring, a wearable designed specifically for women. The Evie Ring combines health and wellness metrics to give a full picture of one's health, which includes resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking.

Share on Social Networks: